Oneness Biotech Co., Ltd. (LUX:ONES)

Oneness Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,099	1,048	812.83	5,655	332.96	217.64
Short-Term Investments	3,663	5,971	6,960	2,392	7,473	8,099
Cash & Short-Term Investments	6,762	7,019	7,773	8,047	7,806	8,317
Cash Growth	-12.15%	-9.70%	-3.40%	3.08%	-6.14%	423.69%
Accounts Receivable	14.15	18.34	25.77	13.08	14.59	444.45
Other Receivables	83.85	77.88	50.77	19.86	114.2	70.37
Receivables	98	96.22	76.54	32.95	128.79	514.82
Inventory	113	115.16	122.74	111.4	81.32	50.19
Other Current Assets	49.86	62.83	45.93	42.2	35.31	55.31
Total Current Assets	7,023	7,293	8,018	8,233	8,051	8,937
Property, Plant & Equipment	1,084	1,106	1,195	1,033	1,038	1,046
Long-Term Investments	3,326	3,737	4,096	3,920	3,871	2,585
Goodwill	-	57.44	89.14	89.14	89.14	89.14
Other Intangible Assets	1,133	1,125	1,682	2,010	2,388	2,474
Long-Term Accounts Receivable	-	-	-	-	32.41	32.94
Long-Term Deferred Tax Assets	137.57	137.57	79.21	97.46	62.85	38.67
Other Long-Term Assets	207.42	204.05	204.05	197.65	197.86	180.73
Total Assets	12,911	13,660	15,364	15,580	15,731	15,384
Accounts Payable	0.67	2.73	1.7	1.52	2.5	48.43
Accrued Expenses	-	103.57	119.05	155.39	78.16	58.6
Current Portion of Leases	42.92	41.18	34.25	13.25	12.73	23.23
Current Income Taxes Payable	0.12	0.12	0.12	12.69	35.1	-
Other Current Liabilities	119.46	35.32	60.24	25.76	28.75	23.44
Total Current Liabilities	163.17	182.92	215.36	208.6	157.24	153.69
Long-Term Leases	353.03	365.18	397.95	250.09	270.34	279.86
Long-Term Unearned Revenue	171.1	170.68	176.07	145.99	1,155	1,155
Long-Term Deferred Tax Liabilities	143.95	140.41	76.56	95.22	58.18	35.09
Other Long-Term Liabilities	0.47	0.47	0.48	0.48	0.48	0.48
Total Liabilities	831.72	859.65	866.43	700.38	1,642	1,625
Common Stock	4,793	4,791	4,545	3,910	3,853	3,771
Additional Paid-In Capital	7,628	7,623	9,050	8,637	9,469	9,157
Retained Earnings	-1,313	-1,154	-1,267	359.98	-1,036	-633.57
Treasury Stock	-25.78	-25.78	-25.78	-25.78	-47.38	-75.81
Comprehensive Income & Other	490.09	1,066	1,750	1,737	1,778	1,415
Total Common Equity	11,573	12,299	14,053	14,618	14,016	13,633
Minority Interest	506.22	501.02	444.07	262.28	72.95	126.38
Shareholders' Equity	12,079	12,800	14,497	14,880	14,089	13,760
Total Liabilities & Equity	12,911	13,660	15,364	15,580	15,731	15,384
Total Debt	395.96	406.35	432.2	263.34	283.07	303.09
Net Cash (Debt)	6,366	6,613	7,341	7,783	7,523	8,014
Net Cash Growth	-12.42%	-9.92%	-5.69%	3.46%	-6.13%	536.11%
Net Cash Per Share	13.38	13.83	15.50	16.50	16.52	18.80
Filing Date Shares Outstanding	477.41	478.03	476.23	466.02	458.4	447.43
Total Common Shares Outstanding	477.41	478.03	476.23	466.02	458.4	447.43
Working Capital	6,860	7,110	7,803	8,025	7,894	8,784
Book Value Per Share	24.24	25.73	29.51	31.37	30.58	30.47
Tangible Book Value	10,440	11,117	12,282	12,519	11,539	11,070
Tangible Book Value Per Share	21.87	23.26	25.79	26.86	25.17	24.74
Buildings	-	640.27	637.35	602.54	580.99	510.38
Machinery	-	554.04	547.55	522.99	456.01	399.52
Construction In Progress	-	1.98	18.24	-	13.03	48.15
Leasehold Improvements	-	58.15	27.56	14.56	14.01	9.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.